Clinical studies in Mexico 2024, by status

Published by
Jennifer Mendoza,
Dec 10, 2024

As of December 2024, a total of 3,169 interventional studies had been completed in Mexico. Meanwhile, another 549 clinical trials were recruiting participants, and 439 studies were terminated in the North American country. The pharmaceutical industry's expenditure on research and development is expected to increase by 3.7 percent in 2024.

Number of registered clinical studies in Mexico as of December 2024, by status

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

December 2024

Region

Mexico

Survey time period

December 10, 2024

Supplementary notes

The source does not provide a publication date. The release date is the date of access.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Clinical trials "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Clinical trials

R&D overview

6

Top R&D companies

5

Clinical studies

7

Participation

4

Costs and market

6

Approvals, launches, setbacks

6

COVID-19

4

Further related statistics

6

Further Content: You might find this interesting as well

Statistics

Topics

Biotech drugsGlobal pharmaceutical industryCancer in the U.S.AmgenCoronavirus (COVID-19) vaccines and treatments
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.